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Bajpeyi S, Tanner CJ, Slentz CA, Duscha BD, McCartney JS,
Hickner RC, Kraus WE, Houmard JA. Effect of exercise intensity
and volume on persistence of insulin sensitivity during training
cessation. J Appl Physiol 106: 1079–1085, 2009. First published
February 5, 2009; doi:10.1152/japplphysiol.91262.2008.—The pur-
pose of this study was to determine whether exercise prescriptions
differing in volume or intensity also differ in their ability to retain
insulin sensitivity during an ensuing period of training cessation.
Sedentary, overweight/obese subjects were assigned to one of three
8-mo exercise programs: 1) low volume/moderate intensity [equiva-
lent of 12 miles/wk, 1,200 kcal/wk at 40–55% peak O2 consump-
tion (V˙ O2peak), 200 min exercise/wk], 2) low volume/vigorous inten-
sity (12 miles/wk, 1,200 kcal/wk at 65–80% V˙ O2peak, 125 min/wk),
and 3) high volume/vigorous intensity (20 miles/wk, 2,000 kcal/wk
at 65–80% V˙ O2peak, 200 min/wk). Insulin sensitivity (intravenous
glucose tolerance test, SI) was measured when subjects were seden-
tary and at 16–24 h and 15 days after the final training bout. SI
increased with training compared with the sedentary condition (P 
0.05) at 16–24 h with all of the exercise prescriptions. SI decreased to
sedentary, pretraining values after 15 days of training cessation in the
low-volume/vigorous-intensity group. In contrast, at 15 days SI was
significantly elevated compared with sedentary (P  0.05) in the
prescriptions utilizing 200 min/wk (low volume/moderate intensity,
high volume/vigorous intensity). In the high-volume/vigorous-inten-
sity group, indexes of muscle mitochondrial density followed a pattern
paralleling insulin action by being elevated at 15 days compared with
pretraining; this trend was not evident in the low-volume/moderate-
intensity group. These findings suggest that in overweight/obese
subjects a relatively chronic persistence of enhanced insulin action
may be obtained with endurance-oriented exercise training; this per-
sistence, however, is dependent on the characteristics of the exercise
training performed.
obesity; physical activity; cardiovascular disease; metabolic syndrome
PHYSICAL ACTIVITY CAN IMPROVE insulin action in individuals
with insulin-resistant conditions such as the metabolic syn-
drome, cardiovascular disease, obesity, and type 2 diabetes (2,
6, 28). This desirable response is, unfortunately, typically
short-lived because insulin sensitivity can decline significantly
after as little as 38 h after the final exercise training bout (14,
25, 32). This transient response should be considered when
designing physical activity programs for the general populace,
because both the magnitude of the improvement in insulin
action and the ability to retain this improvement when not
exercising should be optimized. However, despite such poten-
tially important considerations, the long-term maintenance
characteristics after exercise training is stopped are notably
understudied. The purpose of the present investigation was to
determine whether there are differences between exercise pre-
scriptions commonly used to treat and prevent disease in the
ability to retain the physical activity-induced improvement in
insulin action during a 2-wk period of training cessation.
Possible mechanistic hypotheses for such adaptations were also
explored to the extent that data were available. Persistence of
an exercise-mediated improvement in insulin action would
provide evidence for additional health benefits of endurance-
oriented exercise training beyond the well-characterized short-
term postexercise effects.
MATERIALS AND METHODS
Subjects. These data are part of the Studies of Targeted Risk
Reduction Intervention Through Defined Exercise (STRRIDE) project
described in detail elsewhere (22). Inclusion criterion were sedentary,
overweight/obese [body mass index (BMI) 25 to 35 kg/m2], and
dyslipidemia (either an LDL cholesterol concentration of 130–190
mg/dl or an HDL cholesterol concentration below 40 mg/dl for men or
45 mg/dl for women). Women participants were postmenopausal.
Exclusion criteria included medications that could alter carbohydrate
metabolism, the presence of diabetes, hypertension, or heart disease,
and orthopedic conditions prohibiting exercise. The experimental
protocol was approved by the Institutional Review Boards at Duke
and East Carolina Universities. Subjects provided written informed
consent.
Study design. Subjects were stratified for race, age, and sex and
randomly assigned to one of three exercise training groups. After 8 mo
of supervised exercise, subjects stopped training and insulin action
was assessed 16–24 h after the final training bout and after 15 days of
training cessation. The number of subjects per group (n) were 46 for
the low-volume/moderate-intensity group, 49 for the low-volume/
vigorous-intensity group, and 58 for the high-volume/vigorous-inten-
sity group. Data from these subjects were included in a report (20)
comparing insulin action at only the sedentary vs. 16–24 h postexer-
cise testing points. Data analysis in that report (20) was conducted
before the completion of STRRIDE recruitment; overlap between the
present and previous (20) data at the pretraining and 16–24 h time
points is n 37 for the low-volume/moderate-intensity group, n 28
for the low-volume/vigorous-intensity group, and n  36 for the
high-volume/vigorous-intensity group.
Exercise training. The 8-mo exercise training programs were as
follows (volume/intensity): 1) low volume/moderate intensity [caloric
equivalent of 12 miles/wk, 1,200 kcal/wk at 40–55% peak O2
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consumption (V˙ O2peak)]; 2) low volume/vigorous intensity (12
miles/wk, 1,200 kcal/wk at 65–80% V˙ O2peak), and 3) high volume/
vigorous intensity (20 miles/wk, 2,000 kcal/wk at 65–80%
V˙ O2peak). The training regimens were chosen to compare different
exercise volume (1,200 vs. 2,000 kcal/wk) in groups exposed to the
same training intensity (65–80% V˙ O2peak) and different intensities
(40–55% vs. 65–80% V˙ O2peak) in groups with the same exercise
volume (1,200 kcal/wk). The exercise volumes (1,200 and 2,000
kcal/wk) were consistent with recommendations of the Surgeon Gen-
eral’s report (6) and the Harvard Alumni Study (24). The 65–80%
V˙ O2peak level was chosen because this is the traditional exercise
intensity prescribed for cardiovascular fitness benefits (1). The lower
training intensity (40–55% V˙ O2peak) approximated brisk walking or
moderate-intensity exercise as advised in health guidelines (1, 27, 28).
While exercise volume is expressed in terms of walking or jogging,
the exercise modes included stationary cycling, treadmill, and ellip-
tical trainers in order to enhance variety and adherence. All exercise
sessions were verified by direct supervision and/or use of a heart rate
monitor (Polar Electro, Woodbury, NY). To minimize musculoskeletal
injury, there was an initial ramp period of 2–3 mo followed by 6 mo of
the appropriate exercise prescription. Subjects were counseled to main-
tain body mass and that the goal of the intervention was not weight loss.
After the 8 mo of training, subjects were asked to cease all exercise
and perform only normal daily activities for the subsequent 15 days;
they were offered the incentive that they could reenter the exercise
training program for 3 mo at no cost after adhering to the withdrawal
period. Subjects were questioned at 5 days and 15 days after the last
exercise session to verify that they had not performed physical activity
other than normal activities of daily living. No subjects indicated that
they had performed structured exercise.
Anthropometrics. Body mass was measured to the nearest tenth of a
kilogram on a digital electronic scale at the time that cardiorespiratory
fitness (V˙ O2peak) was determined (before and after training and after 15
days of training cessation). Height was measured to the nearest 0.5 cm
with a stadiometer, and BMI was calculated as mass/height2.
Insulin action. Insulin action was determined with a 3-h intrave-
nous glucose tolerance test (IVGTT) (3). After fasting blood was
obtained, glucose (50%) was injected through a catheter placed in an
antecubital vein at a dose of 0.3 g/kg body mass. Insulin at a dose of
0.025 U/kg body mass was injected at minute 20. Blood samples were
obtained at minutes 2, 3, 4, 5, 6, 8, 10, 12, 14, 16, 19, 22, 25, 30, 40,
50, 60, 70, 80, 90, 100, 120, 140, 160, and 180 and centrifuged, and
plasma was frozen at 80°C for subsequent measurements. Insulin
was measured by immunoassay (Access Immunoassay System, Beck-
man Coulter, Fullerton, CA) and glucose with an oxidation reaction
(YSI model 2300 Stat Plus, Yellow Springs Instruments, Yellow
Springs, OH). An insulin sensitivity index (SI) was calculated with the
minimal model of Bergman et al. (3). Homeostasis model assessment
of insulin resistance (HOMA-IR) was calculated as fasting insulin
(U/ml)  glucose (mmol/l)/22.5 (4).
Cardiorespiratory fitness. Cardiorespiratory fitness was measured
with an incremental, maximal treadmill test as previously described
(12). Briefly, an initial test was performed to screen for underlying
cardiovascular disease and to acclimate the subject. If no evidence for
cardiovascular disease was detected, a second test was conducted to
determine the pretraining V˙ O2peak. Additional V˙ O2peak tests were
performed after the ramp period and periodically during training in
order to modify the exercise workload to maintain the weekly caloric
expenditure prescription. V˙ O2peak was also determined during the final
week of training (after training time point) and 15–18 days after the
final training bout. The V˙ O2peak test at 15–18 days was performed after
the IVGTT to alleviate any acute effect of this exercise bout on
measurements of insulin action. For consistency, testing points for
V˙ O2peak and body mass are denoted as before training, 16–24 h after
training, and 15 days after training, although actual testing times differ
slightly.
Skeletal muscle analyses. To explore possible mechanisms for
changes in insulin action, we examined available muscle biopsy
samples in subjects from each exercise prescription. Muscle was
obtained from the vastus lateralis by a percutaneous needle biopsy
before each IVGTT. Part of the sample was mounted in an optimum
cutting temperature medium (OCT)-tragacanth gum mixture, frozen in
isopentane cooled over liquid nitrogen, and stored in liquid nitrogen
for subsequent histochemical analyses of muscle fiber type (myosin
ATPase staining) (15), intramuscular triglyceride (IMTG) content (Oil
Red O) (15), muscle glycogen content (periodic acid Schiff method)
(29), capillary density (11), and an index of mitochondrial density
(NADH tetrazolium reductase staining) (18). Muscle citrate synthase
(CS) activity was also obtained as an additional index of mitochon-
drial content and determined with a fluorometric end point assay (11).
Sections stained for fiber type, IMTG, NADH, and glycogen
content were viewed under light microscopy. In a previous study in
our laboratory (15) the image taken with10 magnification produced
results similar to 40. Because the 10 magnification encompassed
a larger area, we felt it produced a better representative index of the
variables being measured. When the desired field of view was ob-
tained, software (Spot Advanced 3.2.4, Diagnostic Instruments, Ster-
ling Heights, MI) was used to generate a live image. The image was
digitally captured, stamped with a calibration mark, and saved as a
32-bit tagged image format file. Images taken from serial sections
were used to determine fiber type-specific lipid content as described
previously (15). Sigma Scan Pro 5.0 (SPSS Science, Chicago, IL)
software was used to perform image analysis.
Vascular density, expressed as endothelial cells per muscle fiber
and endothelial cells per square millimeter, was determined by exam-
ining the total number of endothelial cells relative to the number of
muscle fibers via light microscopy. Endothelial cells were identified in
histological sections by immunohistological techniques with an en-
dothelial cell-specific monoclonal antibody (11) as described below.
Sections were cut throughout the tissue block for analysis, ensuring a
homogeneous sample. A minimum of six different 200 fields were
counted, with the mean number of fibers for each sample being 100.
Slides were allowed to come to room temperature and placed in
ice-cold acetone for 2 min and phosphate-buffered saline (PBS) for 5
min. Blocking solution (10% horse serum in PBS) was applied for 1 h
at room temperature. The primary antibody CD-31 (mouse anti-
human CD31, catalog no. BBA7, R&D Systems) was applied for 30
min at room temperature, followed by incubation with a biotinylated
anti-mouse IgG (mouse IgG alkaline phosphatase Vectastain ABC kit,
Vector Laboratories, Burlingame, CA). Immune complexes were
localized with the chromogenic alkaline phosphatase substrate Vector
Red (Vector Laboratories), and levamisole was added to block en-
dogenous alkaline phosphatase activity. The sections were counter-
stained with hematoxylin, dehydrated, and mounted with Cytoseal
XYL (Richard Allen Scientific). The stained slide of human muscle
was placed on the Olympus 1X70 microscope and transferred onto a
computer screen at a magnification of 100 through an Optronics
Engineering DEI-750 camera (Goleta, CA) to the Adobe Premiere
4.2.1 program (San Jose, CA). The image was captured and saved to
the Adobe Photoshop LE program and then opened into the NIH
Image 1.6/ppc program, and the individual muscle fiber was outlined
and total area calculated.
Statistics. Data were compared with a repeated-measures ANOVA
and contrast-contrast comparisons. Relative changes were compared
with between-groups ANOVA. Statistical significance was denoted at
the P  0.05 level. All data are presented as means  SE.
RESULTS
Subjects. Characteristics for subjects that completed the
detraining component of the study (pretraining, 16–24 h, and
15 days of training cessation) with insulin action data are
presented in Table 1. There were no differences between
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groups in age, stature, or BMI. It should be noted that the
numbers per group may differ from previously published
studies from the STRRIDE cohort (12, 20) because the indi-
viduals included in the present analyses were those who had
IVGTT data at all three study points.
Exercise training. Characteristics of the exercise programs
are presented in Table 2. As expected, actual training volume
(kcal of energy expenditure on exercise) per week was highest
in the high-volume/vigorous-intensity group. To achieve the
prescribed volumes (kcal/wk), the low-volume/moderate-in-
tensity and high-volume/vigorous-intensity groups devoted
significantly (P 0.05) more time to training per week and per
exercise session than the low-volume/vigorous-intensity group.
The frequency (sessions per week) needed to attain the as-
signed exercise dosage was significantly (P  0.05) lower in
the low-volume/vigorous-intensity group.
Insulin action. After 8 mo of exercise training, mean SI
increased with all of the exercise prescriptions as determined
16–24 h after the final exercise training bout and compared
with the sedentary pretraining condition (Fig. 1). After 15 days
of training cessation, SI in the low-volume/vigorous-intensity
exercise group declined to a value that was not significantly
different from the sedentary pretraining level (Fig. 1). In
contrast, in both the low-volume/moderate-intensity and high-
volume/vigorous-intensity groups insulin action (SI) at 15 days
remained at a level that was significantly elevated compared
with the sedentary pretraining condition (P  0.05) (Fig. 1).
Insulin action was reduced at 15 days compared with 16–24 h
after training in the low-volume/moderate-intensity, low-vol-
ume/vigorous-intensity (P  0.001), and high-volume/vigor-
ous-intensity (P  0.08) groups (Fig. 1).
Other components of insulin action such as fasting insulin
and HOMA-IR demonstrated an exercise training and subse-
quent detraining main effect with no differences between the
exercise prescriptions. As presented in Table 3, fasting plasma
insulin significantly decreased at 16–24 h after the final training
bout compared with before training and subsequently returned to
sedentary, before training levels after 15 days of training with-
drawal. A similar pattern was evident for HOMA-IR (Table 3).
Body mass. Body mass declined significantly (P  0.0001)
by a mean of1.1 kg from before (sedentary) to 16–24 h after
training and then decreased further (a total of 1.3 kg vs. the
sedentary condition) at 15 days of training cessation. There
were no differences between the exercise prescriptions in the
body mass response (Table 3).
Cardiorespiratory fitness. V˙ O2peak (l/min) increased with
training (Fig. 2). In the low-volume/moderate-intensity group
V˙ O2peak was retained at trained levels after 15 days of training
cessation. In contrast, absolute V˙ O2peak declined significantly at
15 days of training cessation compared with trained values in
the low-volume/vigorous-intensity (5%) and high-volume/
vigorous-intensity (5%) groups; 15 day values, however,




Intensity (n  46)
Low
Volume/Vigorous
Intensity (n  49)
High
Volume/Vigorous
Intensity (n  58)
Age, yr 53.00.8 52.01.0 51.10.8
Height, m 1.710.02 1.710.01 1.720.01
BMI, kg/m2 29.40.4 30.00.4 29.60.3
Race, n (%)
White 38 (83%) 38 (78%) 50 (86%)
AA 8 (17%) 8 (16%) 4 (7%)
Other 0 (%) 3 (6%) 4 (7%)
Sex, n (%)
Female 21 (46%) 21 (43%) 22 (38%)
Male 25 (54%) 28 (57%) 36 (62%)
Parameter values are expressed as means  SE for n subjects. BMI, body
mass index; AA, African American. There were no significant differences
between groups in these parameters (P  0.05).
Table 2. Characteristics of exercise training programs
Variable Low Volume/Moderate Intensity Low Volume/Vigorous Intensity High Volume/Vigorous Intensity
Prescribed intensity, %V˙ O2peak 40–55% 65–80% 65–80%
Prescribed volume, miles/wk 12 12 20
Adherence, % 89.02.0 90.01.7 84.42.1
Actual volume, miles/wk 10.60.2 10.80.2 16.80.4†
Actual time, min/wk 196.55.3* 125.04.2 202.25.7*
Frequency, sessions/wk 3.50.1* 2.90.1 3.50.1*
Time per session, min 58.32.4* 44.01.5 60.13.0*
Data are expressed as means  SE. Prescribed volume, approximate no. of miles per week calorically equivalent to prescribed 14 kcal  kg1  wk1 for the
low-volume groups and 23 kcal  kg1  wk1 for the high-volume group; V˙ O2peak, peak O2 consumption; actual volume, prescribed volume multiplied by rate of
adherence for each subject. Adherence is expressed as % of optimal by dividing actual time spent exercising by time needed to meet defined exercise prescription.
*Significantly different (P  0.05) from the low-volume/vigorous-intensity group; †significantly different (P  0.05) from the low-volume groups.
Fig. 1. Insulin sensitivity index (SI) before exercise training (Pre) and after
16–24 h and 15 days of training cessation. All values are means  SE.
*Significant difference (P  0.05) from all other times points within an
exercise prescription (difference between 16–24 h and 15 days in the high-
volume/vigorous-intensity group, P 0.08); §significant difference (P 0.05)
from Pre (sedentary) in the low-volume/moderate-intensity and high-volume/
vigorous-intensity groups.
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remained significantly elevated compared with before training
(Fig. 2) in all of the exercise prescriptions. Exercise time to
exhaustion (TTE) increased with training and remained ele-
vated after 15 days of no training compared with sedentary
values but declined significantly from the 16–24 h value
(Table 3); there were no differences between the exercise
training groups in TTE.
Skeletal muscle. Some subjects did not have tissue for all
time points; the number of subjects per comparison is indicated
in each presentation. Muscle glycogen content (Fig. 3A) was
elevated at 15 days compared with 16–24 h after training (n 
27, main effect). IMTG content expressed as a lipid accumu-
lation index (n  24) was not altered at either 16–24 h or 15
days after exercise training compared with the sedentary con-
dition (Fig. 3B). Similar to total content, type I- and type
II-specific IMTG content did not change with exercise training
(data not shown). Type I muscle fibers were found to have a
significantly higher IMTG content compared with type II fibers
(P  0.0001).
Measures indicative of mitochondrial density/content are
presented in Fig. 4. A histochemical index of mitochondrial
density (NADH staining) (Fig. 4A) was elevated at 16–24 h
compared with before training (n  29, main effect). In the
high-volume/vigorous-intensity group, histochemically deter-
mined mitochondrial density was significantly elevated at 15
days compared with pretraining (Fig. 4A) (n  10 subjects),
similar to that of insulin action (Fig. 1). Results were similar
for CS activity. As presented in Fig. 4B, there was a main
effect (n  100) for CS activity to increase with exercise
training (16–24 h). CS activity remained significantly (P 
0.05) elevated in the high-volume/vigorous-intensity group
(n  42) after 15 days of training cessation compared with
pretraining.
Vascular density, expressed as endothelial cells per muscle
fiber and endothelial cells per square millimeter (n  146)
exhibited a main effect with exercise training. The number of
endothelial cells per muscle fiber increased (P  0.001) with
exercise training (1.60  0.03 vs. 1.85  0.04 for before vs.
16–24 h after training, respectively) and remained elevated
(P  0.001) compared with the sedentary condition at 15 days
of training cessation (1.81 0.05), with no difference between
prescriptions. Capillary density exhibited a similar pattern of
change, with a significant main effect (P  0.001) with
exercise training (338.0  6.3 vs. 393.1  8.3 capillaries/
mm2), and remained elevated (P  0.001) at 15 days of
Fig. 3. Histochemical determinations of muscle glycogen content (A) and
intramuscular triglyceride content (B) with physical activity and exercise
cessation in each of the 3 exercise prescriptions. *Significant (P  0.05) main
effect for glycogen content compared with 16–24 h after training.
Table 3. Variables that exhibited no statistically significant
differential effect between the three exercise prescriptions






Fasting insulin, U/ml 9.30.5 7.80.4* 9.00.4
Fasting glucose, mg/dl 93.50.7 94.00.8 93.70.9
HOMA-IR 2.10.1 1.90.1* 2.10.1
Body mass, kg 87.21.1 86.11.1* 85.81.1†
TTE, s 783.316.2 927.018.3* 870.618.0†
Data are expressed as means  SE. HOMA-IR, homeostasis model of
insulin resistance; TTE, time to exhaustion during maximal exercise stress test.
*Significantly different (P  0.05) from other time points; †significantly
different (P  0.05) from before training.
Fig. 2. Peak O2 consumption (V˙ O2peak) before exercise training (Pre) and after
16–24 h and 15 days of training cessation. All values are means  SE.
*Significant difference (P  0.05) vs. pretraining (sedentary) in all exercise
groups; ‡significant difference (P  0.05) from after training (16–24 h) in the
low-volume/vigorous-intensity and high-volume/vigorous-intensity groups.
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training withdrawal (377.9  10.5 capillaries/mm2) compared
with the sedentary condition. Muscle fiber type, as determined
with myosin ATPase staining (type I, type II), and muscle fiber
cross-sectional area were not altered with exercise training or
training cessation (data not shown).
Comparison of relative changes. The mean relative change
induced by exercise training or training cessation for each
group was obtained by calculating the individual relative
change for a subject and using this value to derive a mean
relative change for each exercise prescription. Data are pre-
sented in this manner (%) to account for the range of relative
changes and to subsequently determine whether similar pat-
terns of change were evident in SI and other variables offering
possible mechanistic implications. The mean relative changes
over the sedentary condition at 15 days of training cessation in
SI were 	35.2  1.3% for low volume/moderate intensity,
	6.0 0.9% for low volume/vigorous intensity, and	27.4
0.7% for high volume/vigorous intensity. Comparing log-
adjusted values, the mean increase above the sedentary condi-
tion at 15 days was significantly (P  0.05) greater in the
low-volume/moderate-intensity and high-volume/vigorous-in-
tensity groups compared with the low-volume/vigorous-inten-
sity group. The high-volume/vigorous-intensity training group
exhibited the greatest retention of V˙ O2peak over pretraining (sed-
entary) levels at 15 days of training cessation; values were
	5.6 0.1,	3.9 0.2, and	10.6 0.2% for the low-volume/
moderate-intensity, low-volume/vigorous-intensity, and high-vol-
ume/vigorous-intensity groups, respectively. Indicators of mito-
chondrial density (NADH staining and CS activity) demon-
strated a pattern similar to V˙ O2peak, with the increment over the
sedentary condition being the greatest in the high-volume/
vigorous-intensity group (Fig. 4). Other variables such as body
mass, muscle glycogen or IMTG content, capillary density,
muscle fiber type, and fiber cross-sectional area did not exhibit
differential patterns of change between the exercise groups.
Thus, while V˙ O2peak and mitochondrial content remained ele-
vated at 15 days in the high-volume/vigorous-intensity group,
a consistent pattern of change similar to insulin action (increase
over the sedentary condition in both low-volume/moderate-
intensity and high-volume/vigorous-intensity groups; Fig. 1)
was not evident in the variables examined.
DISCUSSION
Endurance-oriented exercise training improves insulin ac-
tion in insulin-resistant individuals (6, 16, 30). The intent of the
present study was to determine which, if any, clinically utilized
exercise prescriptions retain the training-induced improvement
in insulin action during an ensuring period of training cessation
in an at-risk population of overweight/obese individuals. The
main finding of the present investigation was that insulin action
(SI) remained elevated above pretraining sedentary levels after
15 days of training cessation in two of the three exercise
prescriptions examined (low volume/moderate intensity and
high volume/vigorous intensity) (Fig. 1). The persistence of
training-induced improvements in insulin action does not ap-
pear to be due to subjects remaining physically active during
the 15-day training withdrawal period because other studies
examining 10–14 days of training cessation reported a 0 to
7% decline in maximal O2 consumption (V˙ O2max) (8, 9, 17).
The declines in V˙ O2peak from the trained level in the low-
volume/moderate-intensity and high-volume/vigorous-inten-
sity groups in the present study were at the upper end of this
range (5%) (Fig. 1). Also supportive were observed declines
in TTE during the maximal test for all three exercise protocols
(Table 3). Together, these observations suggest that adapta-
tion(s) linked with the low-volume/moderate-intensity and
high-volume/vigorous-intensity but not the low-volume/vigor-
ous-intensity prescriptions resulted in an improvement in in-
sulin action that remained evident at 15 days after the final
exercise training bout (Fig. 1).
Others have also observed a more long-lived influence of
exercise training on insulin action even when training is
stopped. In master athletes, 10 days of inactivity reduced
insulin action to values that were intermediate between young
and older untrained men rather than reverting completely to the
older, sedentary control group; this observation suggests that
there is some retention of a training-related improvement in
insulin action with 10 days of no physical activity (32). Dela
et al. (10) reported a training-induced elevation in insulin
action that persisted after 6 days of inactivity in overweight
subjects. The present data thus support other observations of an
Fig. 4. Changes in histochemical (NADH staining; A) and biochemical (citrate
synthase activity; B) indexes of mitochondrial content/density with exercise
training and training cessation in each of the 3 exercise prescriptions. ‡Sig-
nificant (P  0.05) main effect for mitochondrial density vs. pretraining
(sedentary); §significant difference (P  0.05) from Pre (sedentary) in the
high-volume/vigorous-intensity group.
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improvement in insulin action that persists beyond an early
compensation phase of 2–4 days following a prolonged period
of endurance-oriented exercise training (10, 32). In relation to
magnitude of the response, at 15 days the mean elevation in SI
over the sedentary condition in the low/moderate and high/
vigorous groups was 30% (RESULTS). This contrasts with the
approximate doubling over the sedentary condition we have
reported in similar subjects with identical methods (7, 20, 21)
when an insulin sensitivity index is obtained within 48 h of the
final training bout (Fig. 1). Although the increment in insulin
sensitivity at 15 days of detraining clearly is not similar to that
evident within 24–48 h after the final training bout, the
observed retention at 15 days could be important clinically and
indicative of a persistent effect of exercise training on insulin
action.
In the present study, common components of the exercise
prescriptions where insulin action was retained (Fig. 1) were
weekly exercise duration and frequency. Weekly training du-
ration averaged 200 min/wk in both the low-volume/moder-
ate-intensity and high-volume/vigorous-intensity prescriptions;
this 200 min/wk was obtained with three or four exercise
sessions per week of 60-min duration. This is in contrast to
the low-volume/moderate-intensity prescription, which con-
sisted of exercising 3 days per week for a total of 125 min or
45 min per session (Table 2). This finding suggests that
exercise duration may be a critical factor to consider when
designing exercise prescriptions to optimize the persistence of
the training-induced improvement in insulin action. To our
knowledge, there is no other information concerning retention
characteristics of insulin action with various exercise prescrip-
tions. The present data thus provide the novel finding that the
training-induced improvement in insulin action can be at least
partially retained, but that this persistence is dependent on the
nature of the original exercise exposure. Although weekly
exercise duration and frequency may be very important param-
eters that determine the longevity of insulin action effects, it is
also possible that the beneficial effects of moderate-intensity
exercise at low volume and vigorous-intensity exercise at high
volume result in similar long-term effects, but through differ-
ent mechanisms outside of weekly duration and frequency. It
should be noted that when moderate-intensity and vigorous-
intensity exercise were compared at the same volume (low-
volume/moderate-intensity vs. low-volume/vigorous-intensity
prescriptions; Table 3), the moderate-intensity exercise was
clearly superior (Fig. 1), implying that there is some aspect of
moderate-intensity exercise training that has more beneficial
effects on insulin action than vigorous exercise.
The present study also attempted to provide insight into
possible cellular mechanisms by which the longer-duration
prescriptions conferred a persistence of insulin action. Our
approach was to utilize comparisons of recovery kinetics be-
tween insulin action and candidates for regulation of cellular
insulin action, with the reasoning that if patterns were similar
then a mediator would be considered a good mechanistic
candidate. For instance, glycogen supercompensation can oc-
cur during the early stages of training withdrawal and induce
insulin resistance (13, 19); the accumulation of IMTG is also
associated with insulin resistance at least in sedentary individ-
uals (15, 16). However, when we compared the recovery
kinetics across groups for insulin action (Fig. 1), muscle
glycogen content, and IMTG content (Fig. 3), no pattern
similarities were evident. A noncongruent pattern of change
was also evident for capillary density, muscle fiber type, and
muscle fiber area with insulin action, suggesting no mechanis-
tic link with these variables (RESULTS).
Indicators of mitochondrial density were measured, because
mitochondrial content may be an important factor governing
insulin action (5, 23, 33) and would be anticipated to change
with training and training cessation (5a). Mitochondrial density
reproduced the pattern of change for SI in the high-volume/
vigorous-intensity prescription in that it remained above sed-
entary values at day 15 of training cessation (Figs. 1, 4).
V˙ O2peak was also more highly retained in the high-volume/
vigorous-intensity group with training cessation (RESULTS).
From these observations it could be hypothesized that the
high-volume/vigorous-intensity prescription evoked adapta-
tions that resulted in a more substantial retention of factors
associated with V˙ O2peak and muscle mitochondrial content;
these adaptations could in turn have contributed to the persis-
tence of the training-induced improvement in SI. However, in
the low-volume/moderate-intensity group, in whom SI was also
elevated (Fig. 1), mitochondrial content and V˙ O2peak were not
similarly maintained (Figs. 2, 4), suggesting that different
mechanisms may be responsible for retaining insulin action
with a moderate-intensity training regimen. However, the
present findings could also be interpreted as indicating that the
true cellular mediators responsible for regulating insulin action
in human subjects with a prolonged exercise training program
simply were not measured because no indexes consistently
mimicked the relative increments in SI over the sedentary
condition. The mechanisms that govern insulin action are
multifactorial and complex (14, 16, 17); further studies are
needed to explain why the exercise prescriptions studied pro-
vided persistence of the training-induced improvement in in-
sulin action.
The goal of the STRRIDE project was to provide informa-
tion to aid in determining effective exercise prescriptions for
treating and preventing chronic disease. The present study and
others (20) suggest that exercise prescriptions similar to the
low-volume/moderate-intensity and high-volume/vigorous-in-
tensity (Table 2) programs will confer gains, as well as the
persistence of enhanced insulin action, even over 2 wk after
cessation of the exercise exposure, which may be clinically
significant. It is our hope that this information contributes to a
larger body of evidence that can aid in defining specific
exercise prescriptions that improve and maintain health bene-
fits yet can be realistically performed by sedentary overweight
individuals.
In summary, the present findings suggest there is some
persistence of the training-induced improvement in insulin
action after 15 days of training cessation in middle-aged,
overweight to obese individuals. This effect, however, is de-
pendent on the intensity and weekly amount of exercise em-
ployed during the training period. The cellular mechanisms
responsible for the persistence of insulin sensitivity following
exercise cessation were not obvious in the present study, and
there may be more than one mechanism involved dependent on
the nature of the exercise exposure. These data provide a basis
for exercise training prescriptions in sedentary populations at
risk for the development of diabetes and cardiovascular dis-
ease.
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